Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Income from Continuing Operations (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Income from Continuing Operations data on record, last reported at 802000000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 3719.05% year-over-year to 802000000.0; the TTM value through Dec 2025 reached 965000000.0, up 13685.71%, while the annual FY2025 figure was 210000000.0, 2233.33% up from the prior year.
  • Income from Continuing Operations reached 802000000.0 in Q4 2025 per INDV's latest filing, up from 42000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 802000000.0 in Q4 2025 and bottomed at 98000000.0 in Q2 2024.